®
X
GALA
CONFERENCE
®
WHY BLOOM BURTON & CO?
SERVICES
TRANSACTIONS
TEAM
EVENTS
News & Insights
CAREERS
CONTACT
•
M
E
N
U
•
news
November 13, 2015
Bloom Burton’s analyst David Martin speaks to BNN about Concordia's sell-off and the future of biotech in Canada
Click on the image to view the full video.
RELATED NEWS
See All News
PharmaCorp Announces Closing of C$23 Million Bought Deal Public Offering
Cybin Announces $175 Million Registered Direct Offering
Oliver Technow Receives the 2025 Bloom Burton Award
Eupraxia Pharmaceuticals Announces Closing of US$80.5 Million Public Offering Including Full Exercise of Underwriter Option
Three Finalists Announced for the 2025 Bloom Burton Award
Conavi Medical Corp. Announces Closing of $20M Public Offering
Registration is now open for the 2025 Bloom Burton & Co. Healthcare Investor Conference!
Medexus Pharmaceuticals Announces Closing of $30 Million Overnight Marketed Public Offering of Common Shares
Bloom Burton & Co. Announces the 2025 Bloom Burton Award
The Globe and Mail | AstraZeneca to invest $820 million in Ontario life science sector, says it will create 700 jobs
Click on the image to view the full video.
